Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2,3,4 and 5

Endocrinology
T NickersonH Huynh

Abstract

Insulin-like growth factor binding proteins (IGFBPs) have recently been demonstrated to act as regulators of apoptosis in vitro in both prostate and breast cancer cell lines. We show here that gene expression of IGFBP-2,-3,-4 and -5 increase rapidly in the rat ventral prostate following castration. Increases in IGFBP mRNA levels were detectable by Northern blotting by 6 hours and reached 5 to 10 fold of control levels at 72 hours after castration. Apoptosis in the ventral prostate, as detected in situ by the TUNEL method, was also induced as early as 6 hours after castration. TRPM-2/clusterin, a gene known to be associated with involution of the prostate, was not detected in sham castrated controls but was expressed by 24 hours following androgen ablation. IGF-I mRNA levels increased to 160% of control values within 6 hours following castration, then decreased gradually over the next 72 hours to 35% of control. Affinity labelling experiments demonstrated that IGF-I receptor levels increased initially after castration with peak binding at 24 hours, then declined to levels lower than control. These results suggest that rapid induction of IGFBPs in the rat ventral prostate following androgen ablation may play a role in apoptosis a...Continue Reading

Citations

Apr 6, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·David Danielpour
Jan 29, 2008·American Journal of Therapeutics·Soley SerenOmer Kucuk
Nov 27, 2001·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Bogdan MarekEwa Janczewska-Kazek
Jun 4, 2004·Expert Opinion on Biological Therapy·Kim N Chi, Martin E Gleave
Sep 30, 2004·Toxicology Letters·Silvina M AlvarezMaría Sofía Giménez
Jan 3, 2006·Critical Reviews in Oncology/hematology·C GennigensJ P Droz
Oct 21, 1999·Molecular Genetics and Metabolism·L A WetterauP Cohen
Feb 13, 2001·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·P CohenR G Rosenfeld
Apr 30, 2014·Frontiers in Endocrinology·Andreas HoeflichJulia Brenmoehl
Nov 24, 2006·Technology in Cancer Research & Treatment·Shiwu ZhangBaocun Sun
Oct 6, 2000·International Journal of Urology : Official Journal of the Japanese Urological Association·K MitaT Usui
Dec 6, 2002·Endocrine Reviews·Sue M Firth, Robert C Baxter
Nov 2, 2001·Breast Cancer Research and Treatment·K B LimH Huynh
Jun 11, 1999·Immunology and Cell Biology·A J ButtR C Baxter
Feb 15, 2003·Endocrinology·Nadine Ezer, Bernard Robaire
Jan 31, 2004·Annals of the New York Academy of Sciences·Martin Gleave, Burkhard Jansen
Sep 30, 2015·Reproductive Biology and Endocrinology : RB&E·Julian K ChristiansSonia M Hessels
Mar 11, 2006·The Biochemical Journal·James BeattieDavid J Flint
Jun 5, 2003·The Journal of Biological Chemistry·Alison J ButtRobert C Baxter
Sep 30, 1999·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·M KleffensS L Drop
Mar 27, 2002·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·K McQueeney, C N Dealy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis